SeqOnce Biosciences Adds RT-qPCR Measles Panel
SeqOnce has launched Measles Panel A, a new RT-qPCR assay designed to detect all known measles genotypes—including the D8 genotype.
Read MorePosted by Chris Wolski | Jul 2, 2025 | Sequencing Systems |
SeqOnce has launched Measles Panel A, a new RT-qPCR assay designed to detect all known measles genotypes—including the D8 genotype.
Read MorePosted by Chris Wolski | Jul 2, 2025 | Molecular Diagnostics |
Seegene has launched STAgora, a next-gen infectious disease analytics platform providing real-time, AI-driven insights.
Read MorePosted by Chris Wolski | Jun 27, 2025 | Tuberculosis |
Researchers have developed a handheld TB test that accurately detects tuberculosis in HIV-positive individuals using a single drop of blood.
Read MorePosted by Chris Wolski | Jun 24, 2025 | Emerging & Zoonotic Diseases |
While the current risk to humans of H5N1 remains low, CAP is launching a testing program to help labs better detect and subtype the virus.
Read MorePosted by Chris Wolski | Jun 20, 2025 | Infectious Diseases |
Hepatitis B and C remain major global health threats due to persistent gaps in diagnosis, treatment access, and implementation of care.
Read More